Explore All Access

BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY : Impact Factor & More

eISSN: 1179-9889pISSN: 1179-9889
JournalOpen Access

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Run pre-submission checks

BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY Key Metrics

Time to Publish
time-to-publish View Chart
3
 Mo
Time to Publish

Sign up now and unlock a detailed chart of Time to publish for this journal

% of papers by time taken from submission to publication
0 to 3 months
50%
4 to 6 months
50%
7 to 9 months
0%
Above 9 months
0%

BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2390
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your researchless than 30 sec
Free Report

Recently Published Papers in BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY

View all papers for this journal

Check if your research matches the topics covered in BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY

How long has BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY been actively publishing? expand

BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY has been in operation since 2011 till date.

What is the publishing frequency of BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY? expand

BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY published with a Continuous publication frequency.

How many articles did BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY publish last year? expand

In 2023, BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY publsihed 7 articles.

What is the eISSN & pISSN for BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY? expand

For BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, eISSN is 1179-9889 and pISSN is 1179-9889.

Who is the publisher of BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY? expand

DOVE MEDICAL PRESS LTD is the publisher of BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY.

Global Journal Library:

Cactus Communications Services Pte Ltd
20 McCallum Street, #19-01, Tokio Marine Centre, Singapore 069046

あなたが夢を実現するまで、そのすべてのステップを共に。論文出版と、その前と後につづく一歩一歩を一緒に歩んでいきます。あなたという、自分自身の研究プロジェクトを超えた大切な存在が「もっと」を手にするために。

お役立ちリンク

Researcher.Lifeにご意見をお寄せください

We are always looking for inspiration, feedback, and collaborators

お問い合わせ

Copyright 2024 Cactus Communications. All rights reserved.

Privacy PolicyCookies PolicyTerms of UseCareers